Abiopharma

News list

Burnett Patrick 🔴 sold 2.5K shares of Arcutis Biotherapeutics, Inc. (ARQT) at $28.98 Transaction Date: Jan 05, 2026 | Filing ID: 001241

Full text

News bot Jan. 7, 2026, 10:48 p.m.
🔍 Burnett Patrick (Executive)

Company: Arcutis Biotherapeutics, Inc. (ARQT)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 2,490
Detailed Transactions and Holdings:
- Sold 2,490 shares of Common Stock at $28.9822 per share (Direct)
  Date: 2026-01-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 94,120.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.
- F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.77 to $29.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- REMARKS: Reporting Person's Title: Executive Vice President and Chief Medical Officer